Synergistic role of arabinoxylan rice bran (MGN-3/Biobran) in S. cerevisiae-induced apoptosis of monolayer breast cancer MCF-7 cells

Anticancer Research

Volumn 25, Issue 6 B, 2005, Pages 4187-4196

  Ghoneum, Mamdooh ^a   Gollapudi, Sastry ^b  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; MGN 3; Monolayer MCF 7 cells; Phagocytosis; S. cerevisiae

Indexed keywords

ARABINOXYLAN; BIOBRAN; MGN 3; RICE BRAN EXTRACT; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER GROWTH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HUMAN; HUMAN CELL; MONOLAYER CULTURE; PHAGOCYTOSIS; PRIORITY JOURNAL; RICE BRAN; SACCHAROMYCES CEREVISIAE;

APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG SYNERGISM; HUMANS; PHAGOCYTOSIS; PROBIOTICS; SACCHAROMYCES CEREVISIAE; XYLANS;

EID: 27944494702     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Green DR and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1311, 1998.
2. Hickman JA: Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 11: 121-139, 1992.
3. Martin SJ and Green DR: Apoptosis as a goal of cancer therapy. Curr Opin Oncol 6: 616-621, 1994.
4. Eastman A: Activation of programmed cell death by anticancer agents: cisplatin as a system model. Cancer Cells 2: 275-280, 1990.
5. Friesen C, Herr I, Krammer PH and Debatin KM: Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2: 574-577, 1996.
6. Marchetti P, Mortier L, Beauvillain V and Formstecher P: Are mitochondria targets of anticancer drugs responsible for apoptosis? Ann Biol Clin (Paris) 60: 391-403, 2002.
7. Sorenson CM, Barry MA and Eastman A: Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755, 1990.
8. Andersson A, Fagerberg J, Lewensohn R and Ehrsson H: Pharmacokinetics of cisplatin and its monohydrated complex in humans. J Pharm Sci 85: 824-827, 1996.
9. Lynch, DH, Ramsdell F and Alderson HR: Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16: 569-574, 1995.
10. Arase H, Arase N and Saito T: Fas-mediated cytotoxicity by freshly isolated natural killer cells. J Exp Med 181: 1235-1238, 1995.
11. Velthuis JH, Gavric Z, de Boni HJ and Nagelkerke JF: Impaired activation of caspases and prevention of mitochondrial dysfunction in the metastatic colon carcinoma CC531s-m2 cell line. Biochem Pharmacol 69: 463-471, 2005.
12. Walczak H and Krammer PH: The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256: 58-66, 2000.
13. Houghton AN: Cancer antigens: immune recognition of self and altered self. J Exp Med 180: 1, 1994.
14. Trapani JA, Jans DA, Jans PJ, Smyth MJ, Browne KA and Sutton VR: Efficient nuclear targeting of granzyme B and the nuclear consequences of apoptosis induce by granzyme B and perforin are caspase-dependent, but cell death is caspase-independent. J Biol Chem 273: 27934-27938, 1998.
15. Metkar SS, Wang B, Aguilar-Santelises M, Raja SM et al: Cytotoxic granule-mediated apoptosis: perforin delivers granzyme B-serglycin complexes into target cells without plasma membrane perforation. Immunity 16: 417-428, 2002.
16. Costello RT, Gastaut JA and Olive D: Tumor escape from immune surveillance. Arch Immunol Ther Exp (Warsz) Review 47: 83-88, 1999.
17. Williams N: Tumor cells fight back to beat immune system. Science 274: 1302, 1996.
18. Walker PR, Saas P and Dietrich PY: Role of Fas ligand (CD95L) in immune escape: the tumor cell strikes back. J Immunol 158: 4521-4524, 1997.
19. Rivoltini L, Radrizzani M, Accornero P, Squarcina P et al: Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing. J Immunol 161: 1220-1230, 1998.
20. Filipits M, Pohl G, Rudas M, Dietze O et al: Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J Clin Oncol 23: 1161-1168, 2005.
21. Konig J, Hartel M, Nies AT, Martignoni ME et al: Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma. Int J Cancer 115: 359-367, 2005.
22. Berger W, Setinek U, Hollaus P, Zidek T et al: Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J Cancer Res Clin Oncol 131: 355-363, 2005.
23. Chen L, McGowan P, Ashe S, Johnston J, Li Y, Hellström I and Hellström KE: Tumor immunogenicity determines the effect of B7 costimulation on T-cell-mediated tumor immunity. J Exp Med 179: 523-532, 1994.
24. Kiessling R, Kono K, Petersson M and Wasserman K: Immunosuppression in human tumor-host interaction: role of cytokines and alterations in signal-transducing molecules. Springer Semin Immunopathol 18: 227-242, 1996.
25. Ghoneum M and Grewal I: Change in tumor cell-lymphocyte interactions with age. Hemat Oncol 7: 71-80, 1990.
26. Ghoneum M, Salem F, Shum ST, Perry L and Gill G: In situ lymphophagocytosis by nonlymphoreticular neoplasms. Nat Immun Cell Growth Regul 6: 77-87, 1987.
27. Ghoneum M, Salem F, Allen H and Gill G: Phagocytosis of autologous lymphocytes by cervical preneoplastic and neoplastic cells. Natur Immunt Cell Growth Regul 7: 239-248, 1988.
28. Ghoneum M and Gollapudi S: Phagocytosis of Candida albicans by human metastatic and non-metastatic breast cancer cells in vitro. Cancer Detect Prevent 28: 17-26, 2004.
29. Ghoneum M and Gollapudi S: Induction of apoptosis in human breast cancer cells by Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 24: 1455-1463, 2004.
30. Ghoneum M, Hamilton J, Brown J and Gollapudi S: Human squamous cell carcinoma of the tongue and colon undergoes apoptosis upon phagocytosis of Saccharomyces cerevisiae, the baker's yeast, in vitro. Anticancer Res 25: 981-989, 2005.
31. Petrequin PR and Johnson AG: Macrophage activation by adjuvants in aging mice. J Leukocyte Biol 35: 251-263, 1984.
32. Ghoneum M, Grewal I, Brown J, Osborne R, Elembabi H and Gill G: Phagocytosis of Candida albicans by lymphatic tumor cells in vitro. Acta Histochemica 105: 127-133, 2003.
33. Spudich JA and Lin S: Cytochalasin B, its interaction with actin and actomyosin from muscle. Proc Natl Acad Sci USA 69: 442-446, 1972.
34. Axline SG and Reaven EP: Inhibition of phagocytosis and plasma membrane mobility of the cultivated macrophage by cytochalasin B. Role of subplasmalemmal microfilaments. J Cell Biol 62: 647-659, 1974.
35. Soule HD, Maloney TM, Wolman SR, Peterson WD et al: Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 50: 6075-6086, 1990.
36. Soule HD, Vazquez J, Long A, Albert S and Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 57: 1409-1416, 1973.
37. Madsen MW and Briand P: Relationship between tumorigenicity, in vitro invasiveness, and plasminogen activator production of human breast cell lines. Eur J Cancer 26: 793-797, 1990.
38. Tang CK, Gong XQ, Moscatello DK, Wong AJ and Lippman ME: Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer. Cancer Res 60: 3081-3087, 2000.
39. Ghoneum M and Gollapudi S: Modified arabinoxylan rice bran (MGN-3/Biobran) enhances yeast-induced apoptosis in human breast cancer cells in vitro. Anticancer Res 25: 859-870, 2005.
40. Miyata S, Koshikawa N, Yasumitsu H and Miyazaki K: Trypsin stimulates integrin alpha(5)beta(1)-dependent adhesion to fibronectin and proliferation of human gastric carcinoma cells through activation of proteinase-activated receptor-2. J Biol Chem 275: 4592-4598, 2000.
41. Josefsson EC, Gebhard HH, Stossel TP, Hartwig JH and Hoffmeister KM: The macrophage {alpha}M{beta}2 integrin {alpha}M lectin domain mediates the phagocytosis of chilled platelets. J Biol Chem 280: 18025-18032, 2005.
42. Hoffmeister KM, Felbinger TW, Falet H et al: The clearance mechanism of chilled blood platelets. Cell 112: 87-97, 2003.
43. Cinco M, Murgia R, Presani G and Perticarari S: Integrin CR3 mediates the binding of nonspecifically opsonized Borrelia burgdorferi to human phagocytes and mammalian cells. Infect Immun 65: 4784-4789, 1997.
44. Najmi S, Korah R, Chandra R, Abdellatif M and Wieder R: Flavopiridol blocks integrin-mediated survival in dormant breast cancer cells. Clin Cancer Res 11: 2038-2046, 2005.
45. Horii Y, Iino Y, Maemura M, Horiguchi J and Morishita Y: Inhibitory effects of OK-432 (Picibanil) on cellular proliferation and adhesive capacity of breast carcinoma cells. Oncol Rep 13: 289-294, 2005.
46. Ghoneum M: Anti-HIV activity in vitro of MGN-3, an activated arabinoxylan from rice bran. Biochem Bioph Res Comm 243: 25-29, 1998.
47. Ghoneum M: Enhancement of human natural killer cell activity by modified arabinoxylan from rice bran (MGN-3). Int J Immunother XIV: 89-99, 1998.
48. Ghoneum M and Abedi S: Enhancement of natural killer cell activity of aged mice by modified arabinoxylan rice bran (MGN-3/Biobran). J Pharmacy Pharmacol 56: 1581-1588, 2004.
49. Ghoneum M and Matsuura M: Augmentation of macrophage phagocytosis by modified arabinoxylan rice bran (MGN-3/biobran). Int J Immunopathol Pharmacol 17: 283-292, 2004.
50. Ghoneum M and Gollapudi S: Modified arabinoxylan rice bran (MGN-3/Biobran) sensitizes human T cell leukemia cells to death receptor (CD95)-induced apoptosis. Cancer Lett 20: 41-49, 2003.
51. Stratton MS, Reid ME, Schwartzberg G, Minter FE et al: Selenium and prevention of prostate cancer in high-risk men: the Negative Biopsy Study. Anti-Cancer Drugs 14: 589-594, 2003.
52. Blot WJ, Li JY, Taylor PR et al: Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J Natl Cancer Inst 85: 1483-1492, 1993.
53. Wei WQ, Abnet CC, Qiao YL, Dawsey SM et al: Prospective study of serum selenium concentrations and esophageal and gastric cardia cancer, heart disease, stroke, and total death. Am J Clin Nutr 79: 80-85, 2004.